Tabuniag, Roniel P.

HRN: 27-48-54  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/17/2025
07/23/2025
IV
200mg
Q8
PCAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: